PRIMA-1MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells

被引:0
|
作者
Kotob, Shadi N. [1 ]
Kelts, Jessica L. [1 ]
机构
[1] Univ Michigan Flint, Dept Nat Sci, Flint, MI 48502 USA
来源
ACS OMEGA | 2023年 / 8卷 / 33期
关键词
MUTANT P53; TUMOR-GROWTH; D-RECEPTOR; IN-VIVO; APR-246; INHIBITION; APOPTOSIS; CALCIUM; EB1089; RISK;
D O I
10.1021/acsomega.3c03719
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Vitamin D is a steroidhormone that causes growth suppression incultured cells. We had previously discovered that the triple-negativebreast cancer cell lines MDA-MB-231 and MDA-MB-468 did not have growthsuppression with vitamin D, while MCF-7 did. MCF-7 cells are not triple-negativeand have wild-type p53. Both MDA-MB-231 and MDA-MB-468 have mutationsin p53 and these mutations were a possible explanation for the lackof growth suppression with vitamin D. Our hypothesis was that reactivationof p53 in the triple-negative cell lines would cause them to becomesensitive to vitamin D. We chose to use the small molecule PRIMA-1(MET) to reactivate p53 as it has been previously shown to restorefunction to the p53 mutants present in MB-231 and MB-468. We thenmeasured the ability of vitamin D and its analogues calcipotriol andEB1089 to suppress growth in the presence of PRIMA-1(MET). Here, we show that while PRIMA-1(MET) can kill the breastcancer cells investigated in this study, it does not restore theirsensitivity to vitamin D or its analogues.
引用
收藏
页码:30500 / 30507
页数:8
相关论文
共 50 条
  • [21] Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231
    Russo-Abrahao, Thais
    Lacerda-Abreu, Marco Antonio
    Gomes, Taina
    Cosentino-Gomes, Daniela
    Carvalho-de-Araujo, Ayra Diandra
    Rodrigues, Mariana Figueiredo
    Leal de Oliveira, Ana Carolina
    Rumjanek, Franklin David
    Monteiro, Robson de Queiroz
    Meyer-Fernandes, Jose Roberto
    PLOS ONE, 2018, 13 (02):
  • [22] c-Met downregulation contributes to Metformin-induced inhibition of MDA-MB-468 triple negative breast cancer cells
    Gant, Dana M.
    Ma, Zhikun
    Parris, Amanda B.
    Yang, Xiaohe
    CANCER RESEARCH, 2022, 82 (12)
  • [23] Resveratrol Augments Paclitaxel Treatment in MDA-MB-231 and Paclitaxel-resistant MDA-MB-231 Breast Cancer Cells
    Sprouse, Alyssa A.
    Herbert, Brittney-Shea
    ANTICANCER RESEARCH, 2014, 34 (10) : 5363 - 5374
  • [24] Enhanced oral bioavailability and in vitro evaluation of cannabidiol camel milk-derived exosome formulation in resistant MDA-MB-231 and MDA-MB-468 breast cancer cells
    Aare, Mounika
    Bagde, Arvind
    Nathani, Aakash
    Rishi, Arun K.
    Singh, Mandip
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 663
  • [25] BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436
    Teufelsbauer, Maryana
    Stickler, Sandra
    Eggerstorfer, Marie-Therese
    Hammond, Dennis Clyde
    Hamilton, Gerhard
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 89 - 101
  • [26] BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells
    Zhang, Yan-jun
    Wei, Lichun
    Liu, Mei
    Li, Jie
    Zheng, Yi-qiong
    Gao, Ying
    Li, Xi-ru
    TUMOR BIOLOGY, 2013, 34 (03) : 1605 - 1613
  • [27] Pereskia bleo augments NK cell cytotoxicity against triple-negative breast cancer cells (MDA-MB-231)
    Khalaf, Taif Kareem
    Ismail, Norzila
    Nazri, Nor Amalia
    Ahmed, Naveed
    Yajid, Aidy Irman
    Mohamud, Rohimah
    Kadir, Ramlah
    PEERJ, 2024, 12
  • [28] Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
    Tatiana J. Carneiro
    Ana L. M. Batista Carvalho
    Martin Vojtek
    Inês F. Carmo
    Maria Paula M. Marques
    Carmen Diniz
    Ana M. Gil
    Cancer Cell International, 23
  • [29] Mechanism for ginsenoside Rh2-induced apoptosis of triple-negative breast cancer MDA-MB-231 cells
    Zeng, Y.
    Mao, J.
    Wang, X.
    Yin, B.
    Shen, Z.
    Di, C.
    Gu, W.
    Wu, M.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2020, 47 (01): : 99 - 104
  • [30] Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
    Carneiro, Tatiana J.
    Carvalho, Ana L. M. Batista
    Vojtek, Martin
    Carmo, Ines F.
    Marques, Maria Paula M.
    Diniz, Carmen
    Gil, Ana M.
    CANCER CELL INTERNATIONAL, 2023, 23 (01)